Form 4: FactSet EVP Robie Acquires 8,296 Stock Options
Insider Transaction Report
FactSet Research Systems EVP Robert J. Robie acquired 8,296 employee stock options with an exercise price of $264.57, vesting over four years.
Summary
- Robert J. Robie, Executive Vice President, Institutional Buyside at FactSet Research Systems Inc. (FDS), acquired 8,296 employee stock options.
- The transaction date for the option grant was November 3, 2025.
- Each option has an exercise price of $264.57.
- The options vest 25% annually on the anniversary date of the grant and will be fully vested after four years.
- The expiration date for these options is November 3, 2035.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive. While a routine compensation event, it signifies continued executive commitment and alignment with shareholder interests, which is generally viewed favorably. The potential for future dilution is a minor negative but expected with such grants.
Positives
- The acquisition of stock options by an executive aligns management's financial interests with those of shareholders, incentivizing long-term company performance.
- The vesting schedule encourages executive retention and sustained focus on strategic goals over a four-year period.
Negatives
- The issuance of stock options can lead to potential future dilution for existing shareholders if and when these options are exercised.
Future Outlook
The grant of stock options with a multi-year vesting schedule indicates an expectation of continued employment and a long-term commitment to the company's performance by the executive. The options provide a future incentive tied to the appreciation of FactSet's stock price.
Management Comments
- Robert J. Robie, EVP, Institutional Buyside, acquired employee stock options as part of his compensation package, reflecting a standard practice for executive incentives.
Industry Context
The grant of employee stock options is a common practice in the financial technology and data services industry, including companies like FactSet, to attract, retain, and incentivize key executives. This aligns executive compensation with shareholder value creation, a standard across many publicly traded companies.
Comparison to Industry Standards
- Executive stock option grants are a standard component of compensation packages for senior leadership in the financial services and technology sectors, comparable to practices at companies like S&P Global, MSCI, and Bloomberg (for its public competitors).
- The four-year vesting schedule is typical for long-term incentive plans, aiming to retain talent and align interests over a sustained period, consistent with industry benchmarks.
Stakeholder Impact
- Shareholders: Potential for future dilution if options are exercised, but also benefit from increased executive incentive to drive stock price appreciation.
- Employees (specifically Robert J. Robie): Receives a significant equity incentive, aligning personal wealth creation with company performance.
Next Steps
- The options will vest 25% annually on the anniversary of the grant date (November 3, 2025) over the next four years.
- Robert J. Robie may choose to exercise these options at any time after they vest and before their expiration date of November 3, 2035.
Key Dates
| Date | Description |
|---|---|
| 11/03/2025 | Date of earliest transaction (grant date of employee stock options) |
| 11/03/2026 | First 25% vesting anniversary date (estimated) |
| 11/03/2027 | Second 25% vesting anniversary date (estimated) |
| 11/03/2028 | Third 25% vesting anniversary date (estimated) |
| 11/03/2029 | Fourth 25% vesting anniversary date, fully vested (estimated) |
| 11/03/2035 | Expiration date of the employee stock options |
| 11/05/2025 | Signature date of the reporting person's attorney-in-fact |
Recommendation
holdThis Form 4 filing reports a routine executive compensation event (grant of stock options) and does not contain information that would significantly alter the fundamental outlook or valuation of FactSet. While it signals continued executive alignment, it is not a catalyst for a strong buy or sell recommendation. Investors should 'hold' and consider this as part of the ongoing compensation structure.
Keywords
FactSet, FDS, Stock Options, Executive Compensation, Insider Transaction, Form 4, Equity Grant, Robert J. Robie
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.